2024
Copenhagen, Denmark, 27 November 2024 – Fluoguide A/S (“FluoGuide” or the “Company”) today releases its...
19 November, 2024
Publication of positive phase II clinical data for FG001 in patients with head and neck cancer
Copenhagen, Denmark, 19 November 2024 – FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce...
12 November, 2024
FluoGuide A/S issue warrants to board member, CMO and CFO
Copenhagen, Denmark, 12 November 2024 – FluoGuide A/S (“FluoGuide” or the “Company”) announces issuing...
Copenhagen, Denmark – FluoGuide A/S (“FluoGuide” or the “Company”), a biothech company specializing in...
7 October, 2024
FluoGuide A/S submits Clinical Trial Application for phase II trial in head and neck cancer
Copenhagen, Denmark - FluoGuide A/S (“FluoGuide” or the “Company”), a biothech company specializing in precision...
Copenhagen, Denmark, 29 August 2024 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its...
26 August, 2024
FluoGuide appoints Jens Ellrich as Chief Medical Officer
Copenhagen, Denmark – FluoGuide A/S (“FluoGuide” or the “Company”), a biotech company specializing in...
18 June, 2024
FluoGuide has completed a directed share issue to existing and new investors raising proceeds of SEK 60 million
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA...
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA...
Calendar &
upcoming reports
29 August 2024
27 November 2024
27 February 2025